» Articles » PMID: 26826176

Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives As Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism

Overview
Journal Mol Pharmacol
Date 2016 Jan 31
PMID 26826176
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Crystal structures of CYP2B35 and CYP2B37 from the desert woodrat were solved in complex with 4-(4-chlorophenyl)imidazole (4-CPI). The closed conformation of CYP2B35 contained two molecules of 4-CPI within the active site, whereas the CYP2B37 structure demonstrated an open conformation with three 4-CPI molecules, one within the active site and the other two in the substrate access channel. To probe structure-function relationships of CYP2B35, CYP2B37, and the related CYP2B36, we tested the O-dealkylation of three series of related substrates-namely, 7-alkoxycoumarins, 7-alkoxy-4-(trifluoromethyl)coumarins, and 7-alkoxy-4-methylcoumarins-with a C1-C7 side chain. CYP2B35 showed the highest catalytic efficiency (kcat/KM) with 7-heptoxycoumarin as a substrate, followed by 7-hexoxycoumarin. In contrast, CYP2B37 showed the highest catalytic efficiency with 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC), followed by 7-methoxy-4-(trifluoromethyl)coumarin (7-MFC). CYP2B35 had no dealkylation activity with 7-MFC or 7-EFC. Furthermore, the new CYP2B-4-CPI-bound structures were used as templates for docking the 7-substituted coumarin derivatives, which revealed orientations consistent with the functional studies. In addition, the observation of multiple -Cl and -NH-π interactions of 4-CPI with the aromatic side chains in the CYP2B35 and CYP2B37 structures provides insight into the influence of such functional groups on CYP2B ligand binding affinity and specificity. To conclude, structural, computational, and functional analysis revealed striking differences between the active sites of CYP2B35 and CYP2B37 that will aid in the elucidation of new structure-activity relationships.

Citing Articles

Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond.

Roberts A, Stevens J, Szklarz G, Scott E, Kumar S, Shah M Drug Metab Dispos. 2022; 51(1):111-122.

PMID: 36310033 PMC: 11022898. DOI: 10.1124/dmd.122.001109.


Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6.

McCarty K, Ratliff S, Furge K, Furge L Drug Metab Dispos. 2020; 49(3):179-187.

PMID: 33376147 PMC: 7883074. DOI: 10.1124/dmd.120.000274.


Structure of Cytochrome P450 2C9*2 in Complex with Losartan: Insights into the Effect of Genetic Polymorphism.

Parikh S, Evans C, Obi J, Zhang Q, Maekawa K, Glass K Mol Pharmacol. 2020; 98(5):529-539.

PMID: 32938720 PMC: 7569312. DOI: 10.1124/molpharm.120.000042.


So many roads traveled: A career in science and administration.

Halpert J J Biol Chem. 2020; 295(3):822-832.

PMID: 31953248 PMC: 6970931. DOI: 10.1074/jbc.X119.012206.


Coumarins and P450s, Studies Reported to-Date.

Foroozesh M, Sridhar J, Goyal N, Liu J Molecules. 2019; 24(8).

PMID: 31022888 PMC: 6515222. DOI: 10.3390/molecules24081620.


References
1.
Battye T, Kontogiannis L, Johnson O, Powell H, Leslie A . iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):271-81. PMC: 3069742. DOI: 10.1107/S0907444910048675. View

2.
Shah M, Kufareva I, Pascual J, Zhang Q, Stout C, Halpert J . A structural snapshot of CYP2B4 in complex with paroxetine provides insights into ligand binding and clusters of conformational states. J Pharmacol Exp Ther. 2013; 346(1):113-20. PMC: 3684837. DOI: 10.1124/jpet.113.204776. View

3.
Harlow G, He Y, Halpert J . Functional interaction between amino-acid residues 242 and 290 in cytochromes P-450 2B1 and 2B11. Biochim Biophys Acta. 1997; 1338(2):259-66. DOI: 10.1016/s0167-4838(96)00209-9. View

4.
Hernandez C, Kumar S, Liu H, Halpert J . Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme. Arch Biochem Biophys. 2006; 455(1):61-7. PMC: 1773018. DOI: 10.1016/j.abb.2006.08.024. View

5.
Omura T, Sato R . THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. J Biol Chem. 1964; 239:2379-85. View